Evidence map›Paper›PMID 24043256›Full record

Trial reportAmerican journal of physiology. Heart and circulatory physiology2013

Impact of sex on the heart's metabolic and functional responses to diabetic therapies.

Matthew R Lyons, Linda R Peterson, Janet B McGill, Pilar Herrero, Andrew R Coggan, Ibrahim M Saeed, Carol Recklein, Kenneth B Schechtman, Robert J Gropler

Open access · greenAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in American journal of physiology. Heart and circulatory physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT.Clinical research in cardiology : official journal of the German Cardiac Society · 2017
    Trial
  3. Trial
  4. Article
  5. Sex differences in ventricular muscle energetics in a type 2 diabetic rat model.Cardiovascular diabetology. Endocrinology reports · 2025
    Article
  6. Human cardiac metabolism.Cell metabolism · 2024
    Review
  7. Review
  8. Loss of endothelial glucocorticoid receptor accelerates organ fibrosis inAmerican journal of physiology. Renal physiology · 2023
    Article
  9. Article
  10. Loss of endothelial glucocorticoid receptor accelerates organ fibrosis inbioRxiv : the preprint server for biology · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Heart failure in diabetes.Metabolism: clinical and experimental · 2021
    Review
  16. Article
  17. Observational
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Matthew R LyonsCardiovascular Division, Washington University School of Medicine, St. Louis, Missouri;
Linda R Peterson
Janet B McGill
Pilar Herrero
Andrew R Coggan
Ibrahim M Saeed
Carol Recklein
Kenneth B Schechtman
Robert J Gropler
Washington University in St. Louis · USMallinckrodt (United States) · US

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Jennifer Lynn Powers Carson · 2013 to 2026
$27.1M
YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMESM01RR000036 · NCRR · WASHINGTON UNIVERSITY · PI NEWCOMER, JOHN W. · 1985 to 2007
$25.4M
TRANSGENICS COREP60DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 1986 to 2012
$25.2M
ROLE OF ACE IN PULMONARY HYPERTENSIONP01HL013851 · NHLBI · WASHINGTON UNIVERSITY · PI WELCH, MICHAEL J. · 1985 to 2008
$16.7M
NCRR NIH HHS MO1-RR000036-461599NHLBI NIH HHS P01HL013851-43NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30-DK056341-08NIDDK NIH HHS P60-DK020579-30
6 · The paper itself

Abstract

Increased myocardial lipid delivery is a determinant of myocardial substrate metabolism and function in animal models of type 2 diabetes (T2DM). Sex also has major effects on myocardial metabolism in the human heart. Our aims were to determine whether 1) sex affects the myocardial metabolic response to lipid lowering in T2DM, 2) altering lipid [fatty acid (FA) or triglyceride] delivery to the heart would lower the elevated myocardial lipid metabolism associated with T2DM, and 3) decreasing lipid delivery improves diastolic dysfunction in T2DM. To this end, we studied 78 T2DM patients (43 women) with positron emission tomography, echocardiography, and whole body tracer studies before and 3 mo after randomization to metformin (MET), metformin + rosiglitazone (ROSI), or metformin + Lovaza (LOV). No treatment main effects were found for myocardial substrate metabolism, partly because men and women often had different responses to a given treatment. In men, MET decreased FA clearance, which was linked to increased plasma FA levels, myocardial FA utilization and oxidation, and lower myocardial glucose utilization. In women, ROSI increased FA clearance, thereby decreasing plasma FA levels and myocardial FA utilization. Although LOV did not change triglyceride levels, it improved diastolic function, particularly in men. Group and sex also interacted in determining myocardial glucose uptake. Thus, in T2DM, different therapeutic regimens impact myocardial metabolism and diastolic function in a sex-specific manner. This suggests that sex should be taken into account when designing a patient's diabetes treatment.

Indexed as

Dietary SupplementsHealth Status DisparitiesAnalysis of VarianceChi-Square DistributionDiabetes Mellitus, Type 2DiastoleDocosahexaenoic AcidsDouble-Blind MethodDrug CombinationsEchocardiography, DopplerEicosapentaenoic AcidEnergy MetabolismFatty AcidsFatty Acids, Omega-3FemaleHumansDocosahexaenoic AcidsDrug CombinationsEicosapentaenoic AcidFatty AcidsFatty Acids, Omega-3Hypoglycemic AgentsMetforminOmacorrosiglitazone-metformin combinationThiazolesTriglyceridesLovazametforminmyocardial metabolismrosiglitazonesextype 2 diabetes

Identifiers

PMID24043256
PMCPMC3882467
OpenAlexW2148709684

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.